Pierre Fabre Pharma AG
1 clinical trials · Sponsor
◉ Watch Pierre Fabre Pharma AG
| Record | Firm | Date |
|---|---|---|
| Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). (NCT04318405) | Pierre Fabre Pharma AG | 2020-07-10 |
Track Pierre Fabre Pharma AG automatically
Every clearance here is in the API, with alerts when new ones post.